UPDATE: PTC Therapeutics (PTCT) Initiated Neutral at UBS
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $84.41 --0%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 8
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 8
Join SI Premium – FREE
(Updated - October 27, 2020 5:00 PM EDT)
UBS analyst Colin Bristow started PTC Therapeutics (NASDAQ: PTCT) at Neutral, PT $55.00
You May Also Be Interested In
- Keefe, Bruyette & Woods Starts Arrow Financial Corporation (AROW) at Market Perform
- Kepler Cheuvreux Starts Tryg A/S (TRYG:DC) (TGVSF) at Hold
- Guggenheim Starts Oklo (OKLO) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
